Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Aug 9, 2017 · 10-Q · 40 days after period end · 0001069530-17-000032
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$4.16M | -$3.02M | -$3.37M | -$3.25M |
| EPS Diluted | -$0.64 | -$0.46 | -$0.07 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 9, 2017 · 40 d after period end
